Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Shareholders OK Share Increase for Stock Split

NEW YORK (GenomeWeb News) – Illumina’s shareholders yesterday approved an increase in the number of authorized shares of the firm’s stock to 320 million from 120 million, clearing the way for a proposed 2-for-1 stock split.
 
Illumina had announced the proposed stock split in July. Today is the date of record for the split, and Sept. 22 is the date on which additional shares will be distributed to shareholders.
 
“We believe that the stock split, if effected, may place the market price of our common stock in a range that is more attractive to investors, particularly individuals, which may result in a broader market for our stock,” the firm said in a statement at the time.
 
Illumina’s shares closed at $82.21 yesterday in trading on the Nasdaq, off of a 52-week high of $95.75 reached on July 28. The firm’s shares are up 39 percent since the beginning of the year.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.